Literature DB >> 19846172

Variable phenotypic expression of chylomicron retention disease in a kindred carrying a mutation of the Sara2 gene.

Angelo B Cefalù1, Pier L Calvo, Davide Noto, Maurizio Baldi, Vincenza Valenti, Pietro Lerro, Fabio Tramuto, Antonella Lezo, Isabella Morra, Giovanna Cenacchi, Cristiana Barbera, Maurizio R Averna.   

Abstract

Chylomicron retention disease is a recessive inherited disorder characterized by fat malabsorption and steatorrhea and is associated with failure to thrive in infancy. We describe a kindred carrying a mutation of Sara2 gene causing a chylomicron retention phenotype. The proband was a 5-month-old baby, born of consanguineous, apparently healthy parents from Morocco, with failure to thrive. There was a large quantity of fats in feces and malabsorption of fat-soluble vitamins. Intestinal biopsies showed a diffused enterocyte vacuolization with large cytosolic lipid droplets. Chylomicron retention disease or Anderson disease was hypothesized, and the Sara2 gene was analyzed by direct sequencing. Analysis of the Sara2 gene in the proband identified a 2-nucleotide homozygous deletion in exon 3 leading to a premature stop codon (c.75-76 del TG-L28fsX34). The father was heterozygous for the same mutation, whereas the proband's mother was homozygous, suggesting a variable phenotypic expression of the molecular defect. More studies are needed to understand the reasons of the phenotypic variability of the same molecular defect in the same family. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19846172     DOI: 10.1016/j.metabol.2009.07.042

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  9 in total

Review 1.  Role of the gut in lipid homeostasis.

Authors:  Nada A Abumrad; Nicholas O Davidson
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

Review 2.  Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.

Authors:  Sebastiano Calandra; Patrizia Tarugi; Helen E Speedy; Andrew F Dean; Stefano Bertolini; Carol C Shoulders
Journal:  J Lipid Res       Date:  2011-08-23       Impact factor: 5.922

Review 3.  Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers.

Authors:  Noel Peretti; Agnès Sassolas; Claude C Roy; Colette Deslandres; Mathilde Charcosset; Justine Castagnetti; Laurence Pugnet-Chardon; Philippe Moulin; Sylvie Labarge; Lise Bouthillier; Alain Lachaux; Emile Levy
Journal:  Orphanet J Rare Dis       Date:  2010-09-29       Impact factor: 4.123

4.  Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease).

Authors:  Amandine Georges; Jessica Bonneau; Dominique Bonnefont-Rousselot; Jacqueline Champigneulle; Jean P Rabès; Marianne Abifadel; Thomas Aparicio; Jean C Guenedet; Eric Bruckert; Catherine Boileau; Alain Morali; Mathilde Varret; Lawrence P Aggerbeck; Marie E Samson-Bouma
Journal:  Orphanet J Rare Dis       Date:  2011-01-14       Impact factor: 4.123

5.  The GTPase ARFRP1 controls the lipidation of chylomicrons in the Golgi of the intestinal epithelium.

Authors:  Alexander Jaschke; Bomee Chung; Deike Hesse; Reinhart Kluge; Claudia Zahn; Markus Moser; Klaus-Jürgen Petzke; Regina Brigelius-Flohé; Dmytro Puchkov; Hermann Koepsell; Joerg Heeren; Hans-Georg Joost; Annette Schürmann
Journal:  Hum Mol Genet       Date:  2012-04-14       Impact factor: 6.150

Review 6.  The pathophysiology of intestinal lipoprotein production.

Authors:  Antonina Giammanco; Angelo B Cefalù; Davide Noto; Maurizio R Averna
Journal:  Front Physiol       Date:  2015-03-20       Impact factor: 4.566

7.  Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia.

Authors:  Yanyan Mei; Chao Gao; Kailing Wang; Lei Cui; Weijing Li; Xiaoxi Zhao; Feifei Liu; Minyuan Wu; Guoren Deng; Wei Ding; Hongti Jia; Zhigang Li
Journal:  Cancer Sci       Date:  2014-03-30       Impact factor: 6.716

8.  Chylomicron Retention Disease: a Description of a New Mutation in a Very Rare Disease.

Authors:  Helena Ferreira; Raquel Nuñez Ramos; Cinthia Flores Quan; Susana Redecillas Ferreiro; Vanessa Cabello Ruiz; Javi Juampérez Goñi; Jesus Quintero Bernabeu; Oscar Segarra Cantón; Marina Álvarez Beltran
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2018-04-13

9.  Knockdown of SAR1B suppresses proliferation and induces apoptosis of RKO colorectal cancer cells.

Authors:  Yong Lu; Shen-Kang Zhou; Rui Chen; Liang-Xian Jiang; Lei-Lei Yang; Tie-Nan Bi
Journal:  Oncol Lett       Date:  2020-09-03       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.